| 标题 |
Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Signal Transduction and Targeted Therapy 作者:Junlong Wu; Xinghai Li; Chengyuan Gu; Lixin Hua; Ranlu Liu; et al 出版日期:2026-04-13 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)